Deep Genomics

Deep Genomics in its Series A financing round of approximately US$13 million

Client

Deep Genomics

Value

US$13 million

Service

Corporate Finance and Securities

Date Closed

September 2017

Industry

Health

Lead Office

Toronto


 

On September 25, 2017, Deep Genomics announced its Series A financing round of approximately US$13 million.

The round was led by the U.S. venture capital firm Khosla Ventures, and was joined by True Ventures, which led Deep Genomics’ US$5 million seed financing in 2015.

Deep Genomics is a Toronto-based genetic medicine start-up that develops a machine learning technology to understand how genetic variations lead to diseases and to support geneticists, molecular biologists and chemists in the development of therapies.

Osler, Hoskin & Harcourt LLP represented Deep Genomics with a team consisting of Chad Bayne, Justin Dharamdial, Kate Royer, and Arielle Kaplan (Corporate), and Steven Dickie (Labour & Employment).


Team
Chad Bayne
Key Contact

Chad Bayne

Partner, Corporate

Justin Dharamdial

Justin Dharamdial

Associate, Corporate

Katherine  Royer

Katherine Royer

Associate, Corporate and Energy

Arielle Kaplan

Arielle Kaplan

Associate, Corporate

Steven Dickie

Steven Dickie

Associate, Labour & Employment